Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation

Vincent J. Canzanello, Stephen C Textor, Sandra J Taler, Daniel J. Wilson, Lora Schwartz, Russell H. Wiesner, Michael K. Porayko, Ruud A. Krom

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Hypertension is common after orthotopic liver transplantation and may be due, in part, to cyclosporin A-induced renal dysfunction and/or enhanced proximal tubular sodium reabsorption. To determine whether enhanced proximal tubular sodium reabsorption is central to the development of posttransplant hypertension, measurements of renal hemodynamics and fractional clearances of lithium and sodium were compared 1 month after orthotopic liver transplantation in previously normotensive patients receiving either cyclosporin A (N = 24) or FK506 (N = 18), an immunosuppressive agent that is structurally unlike cyclosporin A and that has a lower reported incidence of hypertension. Median prednisone doses were 20 and 13 mg/day in the cyclosporin A and FK506 groups, respectively (P < 0.05). At 1 month, mean arterial blood pressure was higher in the cyclosporin A versus the FK506 group: 108 ± 2 versus 95 ± 3 mm Hg (P < 0.05). GFR, RBF, and renal vascular resistance were not different between the two groups: 59 ± 4 and 53 ± 5 mL/min per 1.73 m 2, 439 ± 28 and 440 ± 41 mL/min per 1.73 m 2, and 22,429 ± 1,822 and 22,977 ± 3,506 dyne s/cm 5 per 1.73 m 2, respectively. Fractional lithium excretion was similar in the cyclosporin A and FK506 groups: 19.9 ± 2.2 and 19.4 ± 2.0% (P = not significant) although both values were lower than those of normal controls (25.5 ± 1.1%) (P < 0.05). Fractional sodium excretion was 2.7 ± 0.3 and 2.3 ± 0.4% in the cyclosporin A and FK506 groups, respectively (P = not significant). These results indicate that proximal sodium reabsorption is enhanced to a similar degree during treatment with either cyclosporin A or FK506 after orthotopic liver transplantation and cannot per se explain the different incidence of hypertension between the two groups.

Original languageEnglish (US)
Pages (from-to)1910-1917
Number of pages8
JournalJournal of the American Society of Nephrology
Volume5
Issue number11
StatePublished - May 1995

Fingerprint

Tacrolimus
Liver Transplantation
Cyclosporine
Sodium
Kidney
Hypertension
Lithium
Arterial Pressure
Renal Hypertension
Incidence
Immunosuppressive Agents
Prednisone
Vascular Resistance
Hemodynamics

Keywords

  • cyclosporin A
  • FK506
  • hypertension
  • sodium
  • transplantation

ASJC Scopus subject areas

  • Nephrology

Cite this

Canzanello, V. J., Textor, S. C., Taler, S. J., Wilson, D. J., Schwartz, L., Wiesner, R. H., ... Krom, R. A. (1995). Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. Journal of the American Society of Nephrology, 5(11), 1910-1917.

Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. / Canzanello, Vincent J.; Textor, Stephen C; Taler, Sandra J; Wilson, Daniel J.; Schwartz, Lora; Wiesner, Russell H.; Porayko, Michael K.; Krom, Ruud A.

In: Journal of the American Society of Nephrology, Vol. 5, No. 11, 05.1995, p. 1910-1917.

Research output: Contribution to journalArticle

Canzanello, VJ, Textor, SC, Taler, SJ, Wilson, DJ, Schwartz, L, Wiesner, RH, Porayko, MK & Krom, RA 1995, 'Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation', Journal of the American Society of Nephrology, vol. 5, no. 11, pp. 1910-1917.
Canzanello, Vincent J. ; Textor, Stephen C ; Taler, Sandra J ; Wilson, Daniel J. ; Schwartz, Lora ; Wiesner, Russell H. ; Porayko, Michael K. ; Krom, Ruud A. / Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. In: Journal of the American Society of Nephrology. 1995 ; Vol. 5, No. 11. pp. 1910-1917.
@article{973cfaa89b9e4c608614638f094331ba,
title = "Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation",
abstract = "Hypertension is common after orthotopic liver transplantation and may be due, in part, to cyclosporin A-induced renal dysfunction and/or enhanced proximal tubular sodium reabsorption. To determine whether enhanced proximal tubular sodium reabsorption is central to the development of posttransplant hypertension, measurements of renal hemodynamics and fractional clearances of lithium and sodium were compared 1 month after orthotopic liver transplantation in previously normotensive patients receiving either cyclosporin A (N = 24) or FK506 (N = 18), an immunosuppressive agent that is structurally unlike cyclosporin A and that has a lower reported incidence of hypertension. Median prednisone doses were 20 and 13 mg/day in the cyclosporin A and FK506 groups, respectively (P < 0.05). At 1 month, mean arterial blood pressure was higher in the cyclosporin A versus the FK506 group: 108 ± 2 versus 95 ± 3 mm Hg (P < 0.05). GFR, RBF, and renal vascular resistance were not different between the two groups: 59 ± 4 and 53 ± 5 mL/min per 1.73 m 2, 439 ± 28 and 440 ± 41 mL/min per 1.73 m 2, and 22,429 ± 1,822 and 22,977 ± 3,506 dyne s/cm 5 per 1.73 m 2, respectively. Fractional lithium excretion was similar in the cyclosporin A and FK506 groups: 19.9 ± 2.2 and 19.4 ± 2.0{\%} (P = not significant) although both values were lower than those of normal controls (25.5 ± 1.1{\%}) (P < 0.05). Fractional sodium excretion was 2.7 ± 0.3 and 2.3 ± 0.4{\%} in the cyclosporin A and FK506 groups, respectively (P = not significant). These results indicate that proximal sodium reabsorption is enhanced to a similar degree during treatment with either cyclosporin A or FK506 after orthotopic liver transplantation and cannot per se explain the different incidence of hypertension between the two groups.",
keywords = "cyclosporin A, FK506, hypertension, sodium, transplantation",
author = "Canzanello, {Vincent J.} and Textor, {Stephen C} and Taler, {Sandra J} and Wilson, {Daniel J.} and Lora Schwartz and Wiesner, {Russell H.} and Porayko, {Michael K.} and Krom, {Ruud A.}",
year = "1995",
month = "5",
language = "English (US)",
volume = "5",
pages = "1910--1917",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "11",

}

TY - JOUR

T1 - Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation

AU - Canzanello, Vincent J.

AU - Textor, Stephen C

AU - Taler, Sandra J

AU - Wilson, Daniel J.

AU - Schwartz, Lora

AU - Wiesner, Russell H.

AU - Porayko, Michael K.

AU - Krom, Ruud A.

PY - 1995/5

Y1 - 1995/5

N2 - Hypertension is common after orthotopic liver transplantation and may be due, in part, to cyclosporin A-induced renal dysfunction and/or enhanced proximal tubular sodium reabsorption. To determine whether enhanced proximal tubular sodium reabsorption is central to the development of posttransplant hypertension, measurements of renal hemodynamics and fractional clearances of lithium and sodium were compared 1 month after orthotopic liver transplantation in previously normotensive patients receiving either cyclosporin A (N = 24) or FK506 (N = 18), an immunosuppressive agent that is structurally unlike cyclosporin A and that has a lower reported incidence of hypertension. Median prednisone doses were 20 and 13 mg/day in the cyclosporin A and FK506 groups, respectively (P < 0.05). At 1 month, mean arterial blood pressure was higher in the cyclosporin A versus the FK506 group: 108 ± 2 versus 95 ± 3 mm Hg (P < 0.05). GFR, RBF, and renal vascular resistance were not different between the two groups: 59 ± 4 and 53 ± 5 mL/min per 1.73 m 2, 439 ± 28 and 440 ± 41 mL/min per 1.73 m 2, and 22,429 ± 1,822 and 22,977 ± 3,506 dyne s/cm 5 per 1.73 m 2, respectively. Fractional lithium excretion was similar in the cyclosporin A and FK506 groups: 19.9 ± 2.2 and 19.4 ± 2.0% (P = not significant) although both values were lower than those of normal controls (25.5 ± 1.1%) (P < 0.05). Fractional sodium excretion was 2.7 ± 0.3 and 2.3 ± 0.4% in the cyclosporin A and FK506 groups, respectively (P = not significant). These results indicate that proximal sodium reabsorption is enhanced to a similar degree during treatment with either cyclosporin A or FK506 after orthotopic liver transplantation and cannot per se explain the different incidence of hypertension between the two groups.

AB - Hypertension is common after orthotopic liver transplantation and may be due, in part, to cyclosporin A-induced renal dysfunction and/or enhanced proximal tubular sodium reabsorption. To determine whether enhanced proximal tubular sodium reabsorption is central to the development of posttransplant hypertension, measurements of renal hemodynamics and fractional clearances of lithium and sodium were compared 1 month after orthotopic liver transplantation in previously normotensive patients receiving either cyclosporin A (N = 24) or FK506 (N = 18), an immunosuppressive agent that is structurally unlike cyclosporin A and that has a lower reported incidence of hypertension. Median prednisone doses were 20 and 13 mg/day in the cyclosporin A and FK506 groups, respectively (P < 0.05). At 1 month, mean arterial blood pressure was higher in the cyclosporin A versus the FK506 group: 108 ± 2 versus 95 ± 3 mm Hg (P < 0.05). GFR, RBF, and renal vascular resistance were not different between the two groups: 59 ± 4 and 53 ± 5 mL/min per 1.73 m 2, 439 ± 28 and 440 ± 41 mL/min per 1.73 m 2, and 22,429 ± 1,822 and 22,977 ± 3,506 dyne s/cm 5 per 1.73 m 2, respectively. Fractional lithium excretion was similar in the cyclosporin A and FK506 groups: 19.9 ± 2.2 and 19.4 ± 2.0% (P = not significant) although both values were lower than those of normal controls (25.5 ± 1.1%) (P < 0.05). Fractional sodium excretion was 2.7 ± 0.3 and 2.3 ± 0.4% in the cyclosporin A and FK506 groups, respectively (P = not significant). These results indicate that proximal sodium reabsorption is enhanced to a similar degree during treatment with either cyclosporin A or FK506 after orthotopic liver transplantation and cannot per se explain the different incidence of hypertension between the two groups.

KW - cyclosporin A

KW - FK506

KW - hypertension

KW - sodium

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=0029072736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029072736&partnerID=8YFLogxK

M3 - Article

C2 - 7542491

AN - SCOPUS:0029072736

VL - 5

SP - 1910

EP - 1917

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 11

ER -